NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Cary-based Lucerno Dynamics is improving quality control in nuclear medicine injections with its Lara System.
Morrisville-based BioMedomics, a small diagnostics company supported by the North Carolina Biotechnology Center, has developed a new test for rapidly detecting COVID-19.
The North Carolina Biotechnology Center 2020 Company Directory is newly published and free—with all of North Carolina’s industry connections compiled in just 36 pages
Seqirus has received the go-ahead from the FDA to produce its Fluad Quadrivalent vaccine at its Holly Springs factory.
Innovation is a driving force behind the success of Eastern North Carolina's 27-county agricultural economy.
Arbiom, a Durham ag biotech company, says a new study shows its SylPro wood-derived food and feed protein ingredient demonstrated a lower climate impact than fish meal, soy protein concentrate and other protein sources.
Chiesi USA, Inc. and some 150 employees at its Cary headquarters contributed more than $980,000 worth of time and money to Triangle area charities in 2019.
North Carolina’s biopharma manufacturing market is hot at the moment – with an estimated 5,000 new jobs projected for the sector by 2025, according to a recent study.
Pappas Capital, a Durham-based investor in early-stage life sciences companies, has appointed Karen LeVert as venture partner.
Company panelists at NCBiotech's Ag Tech Professional Forum agreed on several key elements affecting their decisions about what products to pursue.
NC's life science leadership is propelled by the healthy growth of RDU.
Durham-based Mycovia Pharmaceuticals has extended its Phase 3 clinical trials of its lead drug candidate for treating recurrent yeast infections in women.
GreenLight Biosciences, headquartered in Boston, expects to double the size of its Research Triangle Park plant and data science operation over the next two years.
Raleigh-based biotechnology company Arrevus has received an Orphan Drug Designation from the FDA for its ARV-1801, an oral antibiotic to treat cystic fibrosis lung infections, .
Bob Jordan, a visionary leader who helped build the foundation for North Carolina’s global life science leadership, died today at the age of 87. 
scroll back to top of page